Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coffee May Protect Against Breast Cancer

By Biotechdaily staff writers
Posted on 20 May 2008
Depending on which variant of a specific gene a woman has, a coffee consumption rate of at least two or three cups a day can either reduce the total risk of developing breast cancer or delay the onset of cancer. More...


This effect has recently been demonstrated in a new study by researchers from Lund University and Malmö University in Sweden. The effect of coffee is related to the female sex hormone estrogen. Specific metabolic products of these hormones are known to be carcinogenic, and various components of coffee can alter the metabolism so that a woman acquires a better configuration of various estrogens. Furthermore, coffee contains caffeine, which also suppresses the growth of cancer cells.

The cancer researcher Dr. Helena Jernström and her associates have examined the coffee-drinking habits of nearly 460 breast cancer patients being treated in Lund. The results demonstrated that the effect of coffee differs depending on which variant of the gene called CYP1A2 the women have. CYP1A2 is the gene that codes for an enzyme that metabolizes both estrogen and coffee. Half of the women had a variant called A/A, while the others had either A/C or C/C. "Those women who had one of the C variants, and who had drunk at least three cups of coffee a day, developed breast cancer considerably more seldom than women with the A/A variant with the same coffee consumption. Their cancer risk was only two-thirds of that of the other women,” observed Dr. Jernström.

A/A women who had drunk two or more cups of coffee a day received more ambiguous help from their coffee consumption. On the one hand, their cancer appeared significantly later than among women who had seldom or never drunk coffee at a mean age of 58 years instead of 48 years, unless they had taken hormone replacement therapy for menopausal symptoms, according to Dr. Jernström. In contrast, nearly 15% of these women had estrogen-insensitive (ER negative) tumors, which are more difficult to treat.

"The majority nevertheless had estrogen-sensitive and more readily treated tumors. And women who develop breast cancer at a higher age often do better than those who get it earlier in life,” stated Dr. Jernström. She cautioned, however, that it is too early to make any dietary recommendations regarding coffee consumption. "This is new information that needs to be corroborated in other studies before we can issue any recommendations. If coffee does in fact provide some protection against breast cancer, then women in such a coffee-drinking country as Sweden ought to have fewer cases of cancer than in other countries. This is also the case, at least compared with the U.S. There the proportion of breast cancer cases in the population is considerably higher, and the people drink both more decaffeinated coffee and less coffee in general.”

The study's findings were published in the April 2008 issue of the journal Cancer Epidemiology, Biomarkers, and Prevention, with doctoral student Erika Bågeman as lead author.


Related Links:
Lund University
Malmö University

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.